BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Purchase Price Allocated to the Underlying Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	May 02, 2022	Dec. 31, 2021	Jun. 23, 2021	Apr. 14, 2021	Jan. 05, 2021	Dec. 31, 2022	Dec. 31, 2020
Acquisition
Goodwill		$ 2,335,172				$ 2,346,040	$ 1,237,672
OmicEra
Acquisition
Net operating assets	$ 2,586
Developed technology	10,000
Total identifiable assets acquired	12,586
Net identifiable assets acquired	8,599
Goodwill	10,809
Net assets acquired	19,408
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	(3,987)
Total purchase price	$ 19,408
PreventionGenetics
Acquisition
Total identifiable assets acquired		95,422
Net identifiable assets acquired		92,802
Goodwill		92,579
Net assets acquired		185,381
Cash and cash equivalents		1,574
Accounts receivable		6,328
Inventory		1,697
Prepaid expenses and other current assets		30
Property, plant and equipment		12,793
Accounts payable		(1,628)
Accrued liabilities		(992)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities		(2,620)
Total purchase price		185,381
PreventionGenetics | Developed technology
Acquisition
Intangible assets		65,000
PreventionGenetics | Customer relationships
Acquisition
Intangible assets		4,000
PreventionGenetics | Trade name
Acquisition
Intangible assets		$ 4,000
Ashion Analytics
Acquisition
Total identifiable assets acquired				$ 56,554
Net identifiable assets acquired				53,241
Goodwill				56,758
Net assets acquired				109,999
Cash and cash equivalents				2,474
Accounts receivable				2,349
Inventory				1,811
Prepaid expenses and other current assets				425
Property, plant and equipment				9,947
Intangible assets				39,000
Accounts payable				(1,477)
Accrued liabilities				(1,190)
Operating lease right-of-use assets				548
Operating lease liabilities, current portion				(343)
Other current liabilities				(98)
Operating lease liabilities, less current portion				(205)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities				(3,313)
Total purchase price				$ 109,999
Thrive
Acquisition
Total identifiable assets acquired					$ 1,564,758
Net identifiable assets acquired					1,238,949
Goodwill					948,105
Net assets acquired					2,187,054
Cash and cash equivalents					241,748
Prepaid expenses and other current assets					3,939
Property, plant and equipment					29,977
Accounts payable					(3,222)
Accrued liabilities					(8,080)
Operating lease right-of-use assets					39,027
Operating lease liabilities, current portion					(2,980)
Operating lease liabilities, less current portion					(38,622)
Other long-term assets					67
In-process research and development (IPR&D)					1,250,000
Deferred tax liability					(272,905)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities					(325,809)
Total purchase price					$ 2,187,054
PFS Genomics
Acquisition
Net identifiable assets acquired			$ 33,569
Cash and cash equivalents			496
Intangible assets			33,074
Total purchase price			33,569
Other assets and liabilities			$ (1)